… early in the disease course, when clinical management is most effective. To aid in …
prognostic classification of disease severity, we perform untargeted metabolomics on plasma …

… serum metabolome in the longitudinal data of 28 severe patients. Our aim was to find not
only prognostic markers of subsequent disease severity … commercial pooled human serum (…

… of disease severity [55]. Future multicenter metabolomics studies on severe COVID-19 are
… Second, our samples, which were only from severe COVID-19 patients with mechanical …

… , plasma samples from COVID-19 patients collected over six longitudinal time points were
analyzed for metabolomic … revealing 25 robust predictor metabolites for disease severity. In …

… The effect size of disease severity on metabolome … and has been used by a number of
large-scale longitudinal cohort … platforms may reveal additional non-lipid metabolomic shifts …

… in longitudinal studies across various COVID-19 waves [44]. … infected-subjects and 120
healthy controls, revealing that the … that correlate with COVID-19 disease severity and viral SARS…

… the disease by interconnecting several factors, primarily through analyzing the metabolomic
profile involved in COVID-19 severity … from other studies in which factors such as underlying …

… et al. in their longitudinal targeted metabolomic study of serum samples … longitudinal study
identified the distinct proteomic and metabolomic profile for the prognosis of COVID-19 severity…

… revealed that 50% of analyzed plasma metabolites showed statistical differences between
COVID-19 and long COVID-19 … participants longitudinally surveyed before and after COVID-19…

… /severe COVID-19 to severe condition 9 . Danlos et al. also reported alterations in the plasma
metabolome … This work also shows that metabolomics is a highly valuable resource for a …